Advertisement

Cost-Utility Analysis of Thumb Carpometacarpal Resection Arthroplasty: A Health Economic Study Using Real-World Data

Published:March 25, 2022DOI:https://doi.org/10.1016/j.jhsa.2022.01.013

      Purpose

      Knowledge about the costs and benefits of hand surgical interventions is important for surgeons, payers, and policy makers. Little is known about the cost-effectiveness of surgery for thumb carpometacarpal osteoarthritis. The objective of this study was to examine patients’ quality of life and economic costs, with focus on the cost-utility ratio 1 year after surgery for thumb carpometacarpal osteoarthritis compared with that for continued nonsurgical management.

      Methods

      Patients with thumb carpometacarpal osteoarthritis indicated for resection arthroplasty were included in a prospective study. The quality of life (using European Quality of Life-5 Dimensions-5 Level), direct medical costs, and productivity losses were assessed up to 1 year after surgery. Baseline data at recruitment and costs sustained over 1 year before surgery served as a proxy for nonsurgical management. The total costs to gain 1 extra quality-adjusted life year and the incremental cost-effectiveness ratio were calculated from a health care system and a societal perspective.

      Results

      The mean European Quality of Life-5 Dimensions-5 Level value for 151 included patients improved significantly from 0.69 to 0.88 (after surgery). The productivity loss during the preoperative period was 47% for 49 working patients, which decreased to 26% 1 year after surgery. The total costs increased from US $20,451 in the preoperative year to US $24,374 in the postoperative year. This resulted in an incremental cost-effectiveness ratio of US $25,370 per quality-adjusted life year for surgery compared with that for simulated nonsurgical management.

      Conclusions

      The calculated incremental cost-effectiveness ratio was clearly below the suggested Swiss threshold of US $92,000, indicating that thumb carpometacarpal surgery is a cost-effective intervention.

      Type of study/level of evidence

      Economic and Decision Analyses II.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Higgins A.M.
        • Harris A.H.
        Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations.
        Crit Care Clin. 2012; 28: 11-24
        • Leafblad N.D.
        • Wagner E.
        • Wanderman N.R.
        • et al.
        Outcomes and direct costs of needle aponeurotomy, collagenase injection, and fasciectomy in the treatment of Dupuytren contracture.
        J Hand Surg Am. 2019; 44: 919-927
        • Camper S.B.
        • Divino V.
        • Hurley D.
        • DeKoven M.
        Cost per episode of care with collagenase Clostridium histolyticum versus fasciectomy for Dupuytren contracture: a real-world claims database analysis.
        J Hand Surg Glob Online. 2019; 1: 57-64
        • Brazzelli M.
        • Cruickshank M.
        • Tassie E.
        • et al.
        Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation.
        Health Technol Assess. 2015; 19: 1-202
        • Billig J.I.
        • Nasser J.S.
        • Chung K.C.
        National prevalence of complications and cost of small joint arthroplasty for hand osteoarthritis and post-traumatic arthritis.
        J Hand Surg Am. 2020; 45: 553.e1-553.e12
        • Squitieri L.
        • Chung K.C.
        • Hutton D.W.
        • Burns P.B.
        • Kim H.M.
        • Mahmoudi E.
        A 5-year cost-effectiveness analysis of silicone metacarpophalangeal arthroplasty in patients with rheumatoid arthritis.
        Plast Reconstr Surg. 2015; 136: 305-314
        • Brügger U.
        • Plessow R.
        • Hess S.
        • et al.
        The health technology assessment of the compulsory accident insurance scheme of hand transplantation in Switzerland.
        J Hand Surg Eur Vol. 2015; 40: 914-923
        • Marks M.
        • Vliet Vlieland T.P.
        • Audigé L.
        • Herren D.B.
        • Nelissen R.G.
        • van den Hout W.B.
        Healthcare costs and loss of productivity in patients with trapeziometacarpal osteoarthritis.
        J Hand Surg Eur Vol. 2015; 40: 927-934
        • Wajon A.
        • Vinycomb T.
        • Carr E.
        • Edmunds I.
        • Ada L.
        Surgery for thumb (trapeziometacarpal joint) osteoarthritis.
        Cochrane Database Syst Rev. 2015; 2015CD004631
        • Lane J.C.
        • Rodrigues J.N.
        • Furniss D.
        • Burn E.
        • Poulter R.
        • Gardiner M.D.
        Basal thumb osteoarthritis surgery improves health state utility irrespective of technique: a study of UK Hand Registry data.
        J Hand Surg Eur Vol. 2020; 45: 436-442
        • Wolf J.M.
        • Atroshi I.
        • Zhou C.
        • Karlsson J.
        • Englund M.
        Sick leave after surgery for thumb carpometacarpal osteoarthritis: a population-based study.
        J Hand Surg Am. 2018; 43: 439-447
        • de Putter C.E.
        • Selles R.W.
        • Polinder S.
        • Panneman M.J.
        • Hovius S.E.
        • van Beeck E.F.
        Economic impact of hand and wrist injuries: health-care costs and productivity costs in a population-based study.
        J Bone Joint Surg Am. 2012; 94: e56
        • Brouwer W.
        • van Baal P.
        • van Exel J.
        • Versteegh M.
        When is it too expensive? Cost-effectiveness thresholds and health care decision-making.
        Eur J Health Econ. 2019; 20: 175-180
        • McCabe C.
        • Claxton K.
        • Culyer A.J.
        The NICE cost-effectiveness threshold:what it is and what it means.
        Pharmacoeconomics. 2008; 26: 733-744
        • Thokala P.
        • Ochalek J.
        • Leech A.A.
        • Tong T.
        Cost-effectiveness thresholds: the past, the present and the future.
        Pharmacoeconomics. 2018; 36: 509-522
        • Vanness D.J.
        • Lomas J.
        • Ahn H.
        A health opportunity cost threshold for cost-effectiveness analysis in the United States.
        Ann Intern Med. 2021; 174: 25-32
        • Neumann P.J.
        • Cohen J.T.
        • Weinstein M.C.
        Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold.
        N Engl J Med. 2014; 371: 796-797
        • Cameron D.
        • Ubels J.
        • Norstrom F.
        On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review.
        Glob Health Action. 2018; 11: 1447828
      1. Swiss Federal Statistical Office. Gross domestic product per capita.
        • Husereau D.
        • Drummond M.
        • Petrou S.
        • et al.
        Consolidated health economic evaluation reporting standards (CHEERS) statement.
        Int J Technol Assess. 2013; 29: 117-122
        • Walters S.J.
        • Brazier J.E.
        Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
        Qual Life Res. 2005; 14: 1523-1532
        • Epping W.
        • Noack G.
        Surgical treatment of the saddle joint arthrosis.
        Handchir Mikrochir Plast Chir. 1983; 15: 168-176
        • Weilby A.
        Tendon interposition arthroplasty of the first carpo-metacarpal joint.
        J Hand Surg Br. 1988; 13: 421-425
        • Sigfusson R.
        • Lundborg G.
        Abductor pollicis longus tendon arthroplasty for treatment of arthrosis in the first carpometacarpal joint.
        Scand J Plast Reconstr Surg Hand Surg. 1991; 25: 73-77
        • Marks M.
        • Hensler S.
        • Wehrli M.
        • Scheibler A.G.
        • Schindele S.
        • Herren D.B.
        Trapeziectomy with suspension-interposition arthroplasty for thumb carpometacarpal osteoarthritis: a randomized controlled trial comparing the use of allograft versus flexor carpi radialis tendon.
        J Hand Surg Am. 2017; 42: 978-986
        • Herdman M.
        • Gudex C.
        • Lloyd A.
        • et al.
        Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).
        Qual Life Res. 2011; 20: 1727-1736
        • Ludwig K.
        • Graf von der Schulenburg J.
        • Greiner W.
        German value set for the EQ-5D-5L.
        Pharmacoeconomics. 2018; 36: 663-674
        • Grobet C.
        • Marks M.
        • Tecklenburg L.
        • Audigé L.
        Application and measurement properties of EQ-5D to measure quality of life in patients with upper extremity orthopaedic disorders: a systematic literature review.
        Arch Orthop Trauma Surg. 2018; 138: 953-961
        • Eaton R.G.
        • Glickel S.Z.
        Trapeziometacarpal osteoarthritis: staging as a rationale for treatment.
        Hand Clin. 1987; 3: 455-471
        • Reilly M.C.
        • Zbrozek A.S.
        • Dukes E.M.
        The validity and reproducibility of a work productivity and activity impairment instrument.
        Pharmacoeconomics. 1993; 4: 353-365
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009; 42: 377-381
        • Briggs A.H.
        • Wonderling D.E.
        • Mooney C.Z.
        Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.
        Health Econ. 1997; 6: 327-340
      2. Reilly Associates. Health outcomes research.
        http://www.reillyassociates.net/Index.html
        Date accessed: March 27, 2019
        • Marks M.
        • Audigé L.
        • Reissner L.
        • Herren D.B.
        • Schindele S.
        • Vliet Vlieland T.P.
        Determinants of patient satisfaction after surgery or corticosteroid injection for trapeziometacarpal osteoarthritis: results of a prospective cohort study.
        Arch Orthop Trauma Surg. 2015; 135: 141-147
        • Stukstette M.J.
        • Dekker J.
        • Den Broeder A.A.
        • Westeneng J.M.
        • Bijlsma J.W.
        • Van Den Ende C.H.
        No evidence for the effectiveness of a multidisciplinary group based treatment program in patients with osteoarthritis of hands on the short term; results of a randomized controlled trial.
        Osteoarthritis Cartilage. 2013; 21: 901-910
        • Spaans A.J.
        • van Minnen L.P.
        • Kon M.
        • Schuurman A.H.
        • Schreuders A.R.
        • Vermeulen G.M.
        Conservative treatment of thumb base osteoarthritis: a systematic review.
        J Hand Surg Am. 2015; 40: 16-21
        • Bertozzi L.
        • Valdes K.
        • Vanti C.
        • Negrini S.
        • Pillastrini P.
        • Villafane J.H.
        Investigation of the effect of conservative interventions in thumb carpometacarpal osteoarthritis: systematic review and meta-analysis.
        Disabil Rehabil. 2015; 37: 2025-2043
        • Williams M.A.
        • Williamson E.M.
        • Heine P.J.
        • et al.
        Strengthening and stretching for rheumatoid arthritis of the hand (SARAH). A randomised controlled trial and economic evaluation.
        Health Technol Assess. 2015; 19: 1-222
        • Grobet C.
        • Audigé L.
        • Eichler K.
        • et al.
        Cost-utility analysis of arthroscopic rotator cuff repair: a prospective health economic study using real-world data.
        Arthrosc Sports Med Rehabil. 2020; 2: e193-e205
        • Grobet C.E.
        • Glanzmann M.C.
        • Eichler K.
        • et al.
        Cost-utility analysis of total shoulder arthroplasty: a prospective health economic study using real-world data.
        J Shoulder Elbow Surg. 2021; 30: 1998-2006
        • Zhuang T.
        • Wong S.
        • Aoki R.
        • Zeng E.
        • Ku S.
        • Kamal R.N.
        A cost-effectiveness analysis of corticosteroid injections and open surgical release for trigger finger.
        J Hand Surg Am. 2020; 45: 597-609
        • Robinson L.S.
        • Sarkies M.
        • Brown T.
        • O'Brien L.
        Direct, indirect and intangible costs of acute hand and wrist injuries: a systematic review.
        Injury. 2016; 47: 2614-2626
        • Weiss A.P.
        • Kamal R.N.
        • Paci G.M.
        • Weiss B.A.
        • Shah K.N.
        Suture suspension arthroplasty for the treatment of thumb carpometacarpal arthritis.
        J Hand Surg Am. 2019; 44: 296-303
        • Cebrian-Gomez R.
        • Lizaur-Utrilla A.
        • Sebastia-Forcada E.
        • Lopez-Prats F.A.
        Outcomes of cementless joint prosthesis versus tendon interposition for trapeziometacarpal osteoarthritis: a prospective study.
        J Hand Surg Eur Vol. 2019; 44: 151-158
        • Neutel N.
        • Houpt P.
        • Schuurman A.H.
        Prognostic factors for return to work and resumption of other daily activities after traumatic hand injury.
        J Hand Surg Eur Vol. 2019; 44: 203-207